Erratum
In the original article [1], the following information was omitted from the funding section:
“This study was supported by a faculty research grant of Yonsei University College of Medicine for 2009 (6-2009-0101).”
Reference
Yang, et al. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Respir Res. 2016;15(1):148.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s12931-014-0148-4.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Yang, PS., Kim, DH., Lee, Y.J. et al. Erratum to: Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Respir Res 17, 142 (2016). https://doi.org/10.1186/s12931-016-0458-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12931-016-0458-9